The Smoking Gun of AIDS: a 1971 Flowchart

Post useful information that you yourself have tried. Treatments that arent part of the Medical Death Cartel Monopoly. Treatment centers that offer real hope.... Healthy Foods, vitamins, minerals... sources for them etc....
Site Admin
Posts: 7781

The Smoking Gun of AIDS: a 1971 Flowchart

Post#1 » Thu Oct 13, 2005 1:00 am

The Smoking Gun of AIDS: a 1971 Flowchart
by Boyd E. Graves, J.D.
December 6, 2000

In 1977, a secret federal virus program produced 15,000 gallons of AIDS. The record reveals the United States was represented by Dr. Robert Gallo and the USSR was represented by Dr. Novakhatsky of the diabolical Ivanosky Institute. On August 21, 1999, the world first saw the flowchart of the plot to thin the Black Population.

The 1971 AIDS flowchart coordinates over 20,000 scientific papers and fifteen years of progress reports of a secret federal virus development program. The epidemiology of AIDS is an identical match to the "research logic" identified in the five section foldout. The flowchart is page 61 of Progress Report #8 (1971) of the Special Virus program of the United States of America. We today, challenge world scientists to discussion of this document find.

We believe there is a daily, growing number of world experts who are all coming to the same conclusion regarding the significance of the flowchart. Dr. Garth Nicolson has examined the flowchart as well as other top experts from around the world. It is time for Dr. Michael Morrissey of Germany to examine the flowchart and report to the world. In addition, we have now examined the 1978 report. It is heresy to continue to further argue the program ended in 1977.

The 1978 report of the development of AIDS leaves no doubt as to the ("narrow result") candidate virus sought by the United States. The flowchart conclusively proves a secret federal plot to develop a "contagious cancer" that "selectively kills."

Following the presentation of the flowchart in Canada, the same information was presented to the United States in the rotunda of the Western Reserve Historical Society in Cleveland. Shortly thereafter a major African newspaper called and for four days in a row, this issue was the feature story in an uncensored press. The people of Africa already know about the U.S. virus development program. It is time for the rest of us to know.

In January, the U.S. had no response to my two page abstract submitted to the African American AIDS 2000 conference. In February, the U.S. Congress had no response to the 3000 Americans who signed signature petitions calling for immediate review of the flowchart and progress reports of the secret virus development program. We firmly believe once the dust settles from the current election marathon, reviewing the special virus program will be the single most important pursuit of the 21st Century.

More scientists and doctors must join with Dr. Nicolson, Dr. Strecker, Dr. Cantwell, Dr. Horowitz, Dr. Lee, Dr. Wainwright, Dr. Halstead and Professor Boyle. In any public debate on this issue, we will continue to present the flowchart of the secret virus development program, as the "irrefutable missing link" in the true laboratory origin of AIDS.

We have successfully navigated a federal maze and matrix and found a curtain surrounding the issue of AIDS. The 1999 discovery and presentation of the AIDS flowchart is a "smoke detector" wake up call. Society has an obligation to do more than don masks.

Non-inclusive random endnotes:

U.S. Special Virus program, Progress Report #8 (1971), pg. 61 (the flowchart)

National Security Defense Memorandum (NSDM) #314, Brent Scowcroft (1975).

"Special Message to the U.S. Congress on Problems of Population Growth", Richard M. Nixon, July 18, 1969

Public Law 91-213, "To Stabilize World Populations", John D. Rockefeller, III, Chairman, March 16, 1970

National Security Council Memorandum (NSCM) #46, "Black Africa and the U.S. Black Movement", Zbigniew Brezinski, March 17, 1978

Click here to download the 1971 U.S. Special Virus Research Logic Flow Chart!

~ average download time varies ~

1 have accessed Dr. Graves' essay on the 1971 Special Virus Research Logic Flow Chart since February 15, 2001. Dr. Graves has provided copies of the U.S. Virus Flow Chart to many medical doctors, public health experts, and members of Congress. To preview expert commentary on Dr. Graves' 1971 U.S. Special Virus Flow Chart discovery,click here.





Site Admin
Posts: 7781

The Gay Experiment That Started AIDS In America

Post#2 » Mon Dec 05, 2005 8:50 am

The Gay Experiment That Started AIDS In America
By Alan Cantwell, M.D

There is no doubt that AIDS erupted in the U.S. shortly after government-sponsored hepatitis B vaccine experiments (1978-1981) using gay men as guinea pigs. The epidemic was caused by the "introduction" of a new retrovirus (the human immunodeficiency virus, or HIV for short); and the introduction of a new herpes-8 virus, the virus that causes Kaposi's sarcoma, widely known as the "gay cancer" of AIDS. The taboo theory that AIDS is a man-made disease is largely based on research showing an intimate connection between government vaccine experiments and the outbreak of "the gay plague"

The widely accepted theory is that HIV/AIDS originated in a monkey or chimpanzee virus that "jumped species" in Africa. However, it is clear that the first AIDS cases were recorded in gay men in Manhattan in 1979, a few years before the epidemic was first noticed in Africa in 1982. It is now claimed that the human herpes-8 virus (also called the KS virus), discovered in 1994, also originated when a primate herpes virus jumped species in Africa. How two African species-jumping viruses ended up exclusively in gay men in Manhattan beginning in the late 1970s has never been satisfactorily explained.

Researchers who claim AIDS is a man-made disease believe it is much more likely that these two primate viruses were introduced and spread during the government's recruitment of thousands of male homosexuals beginning in 1974.

Large numbers of gay men in Manhattan donated blood for the experimental hepatitis B vaccine trial, which took place at the New York Blood Center in Manhattan in 1978. Extensive evidence supporting the man-made theory of AIDS is easily found on the Internet by Googling: man-made origin of AIDS; and in my two books, "AIDS and the Doctors of Death" and "Queer Blood: The Secret AIDS Genocide Plot."

Government interest in "gay health" before the AIDS epidemic

Beginning in the mid-1970s, government scientists became interested in the health of gay men, particularly in the realm of sexually-transmitted diseases, and specifically in the sexual transmission of the hepatitis B virus. The early 1970s was a time when large numbers of gays come out of the closet and identified themselves as homosexuals at government-sponsored health clinics. Organizations such as the Gay Men's Health Project were formed at this time. Promiscuous gays were avidly sought as volunteers to test the efficacy of a newly-developed hepatitis B vaccine manufactured by Merck and the National Institutes of Health (NIH).

By 1977 over 13,000 Manhattan gays were screened to secure the final 1083 men who would serve as guinea pigs to test the hepatitis B vaccine. The vaccine was manufactured from the combined plasma of 30 highly selected gay men who carried the hepatitis B virus in their blood. Developed over a period of 65 weeks during 1977-1978 and tested for six months in chimpanzees (the primate in which HIV is thought to have originated), the first group of gay men were inoculated at the New York Blood Center in November 1978.

That same year a final cohort of 6875 homosexual men at the San Francisco City Clinic was assembled to study hepatitis B virus sexual transmission in that city. By the end of the decade gays in clinics in Los Angeles, Denver, Chicago, and St. Louis, also came under surveillance by the Centers for Disease Control. An additional 1402 volunteers were finally selected to participate in similar vaccine experiments in those cities beginning in March 1980.

Before 1978 there was no stored blood anywhere in the U.S. that tested positive for HIV or the KS virus. There were no cases of AIDS and no cases of "gay cancer" in young men.
The first cases of AIDS appeared shortly after the experiment began in Manhattan. In June 1981 the epidemic became official and was quickly labeled the "gay ­related immune deficiency syndrome", later known as AIDS.

The gay community was the most hated minority in America. After the experiments ended, the gay community was decimated by the "gay plague." In the first years of AIDS, the epidemic was largely ignored by the government (see Randy Shilt's best-seller, "And the Band Played On") and the disease was blamed on gay anal sex, drugs, and promiscuity. Gays were immediately labeled "high risk."

In my view, what made gay men "high risk" was the fact that they were the exclusive volunteers for government medical experiments that undoubtedly put them at "high risk." The evidence for this conclusion is outlined in this report. Further evidence can be obtained from abstracts of scientific reports available on the Internet at the PubMed website of the National Library of Medicine.

The gay hepatitis B experiments (1978-1981)

The experimental hepatitis B vaccine injected into gays was unlike any other vaccine previously made. As stated, it was developed in chimpanzees and manufactured in a year-long process of sterilization and purification of the pooled blood of 30 gay men who were hepatitis B virus carriers.

The final group of 1083 selected for the first experiment at the Blood Center were inoculated from November 1978 until October 1979. At one point, there was great concern that the vaccine might be contaminated. According to June Goodfield's Quest for the Killers, p 86, "This was no theoretical fear, contamination having been suspected in one batch made by the National Institutes of Health, though never in Merck's." Each gay man was given three inoculations of the vaccine over a period of three months. The vaccine proved successful with 96% of the men developing protective antibodies against the hepatitis B virus.

It has been assumed by some that these men might have been already immunosuppressed due to promiscuity and venereal disease. Although the young men in the study were indeed "promiscuous" (this was a requirement for entrance into the study), they were in excellent health. Despite many previous sexual partners, these volunteers had never been infected with the hepatitis B virus, which was a requirement for participation in the experiment. Furthermore, the 96% success rate would not have been accomplished if the men were immunosuppressed, because such people often do not respond to the vaccine.
When Robert Gallo's blood test for HIV became available in the mid-1980s, the New York Blood Center's stored gay blood specimens were reexamined. Most astonishing is the fact that 20% of the gay men who volunteered for the hepatitis B experiment in Manhattan were discovered to be HIV-positive in 1980 (one year before the AIDS epidemic became "official" in 1981). This signifies that Manhattan gays in 1980 had the highest incidence of HIV anywhere in the world, including Africa, the supposed birthplace of HIV and AIDS. In addition, we now know that one out of five gay men (20%) tested positive for the new KS herpes-8 virus in 1982 when stored blood samples from an AIDS trial in New York City were re-examined by epidemiologists at the NCI in 1999.

Never mentioned by AIDS historians is the fact that the New York Blood Center established a chimp virus laboratory for viral vaccine research in West Africa in 1974. One of the purposes of VILAB II, in Robertsfield, Liberia, was to develop the hepatitis B vaccine in chimps. The lab also prides itself by releasing "rehabilitated" (but virus-infected) chimps back into the wild, perhaps accounting for some of the ancestors of HIV and the KS virus found in the jungle by some government researchers.
The Virus Cancer Program and the birth of AIDS
In the decade before AIDS the Virus Cancer Program (1968-1980), sponsored by the National Institutes of Health, attempted to prove that viruses caused human cancer. Ultimately the Program was unsuccessful in providing proof, yet it succeeded in building up the field of animal retrovirology, which led to a more complete understanding of how cancer-causing and immunosuppressive viruses in animals might cause disease in humans. The VCP was also the birthplace of genetic engineering, molecular biology, and the human genome project. As the VCP was winding down in the late 1970s, the gay experiments began in New York City.

The introduction of HIV and the KS herpes virus into gay men during this period (along with some "novel" and now-patented mycoplasmas discovered at the Armed Forces Institute of Pathology) miraculously revived the career of Robert Gallo and made him the most famous virologist in the world. And, of course, turned the "failure" of the VCP into a triumph by providing proof that these primate-derived viruses could cause disease in humans.

The fear of the hepatitis B vaccine

When AIDS began there were scattered reports in the medical journals questioning whether the "gay plague" might have its origin in the hepatitis B experiments. It was well-known in medical circles that the vaccine was made from the pooled plasma of gay men - and there was fear that the AIDS agent might be in the vaccine. As a result, when the hepatitis B commercial vaccine became available in July 1982, many people refused to be injected with it.

The fear of the vaccine was readily admitted by the CDC. Nevertheless, in detailed reports the CDC concluded that the vaccine was safe. Although it was clear the hepatitis B vaccine eliminated all "known" viruses, this obviously did not apply to "unknown" viruses at the time, such as HIV and the KS virus.

After HIV was discovered in 1984 some of the vaccine was retested and declared free of HIV. Of course, it was impossible to say whether the vaccine contained the KS virus, because this virus was undiscovered until 1994. I am unaware of any subsequent testing of the vaccine for this herpes KS virus.

Possible contamination problems with the hepatitis vaccine was the impetus that led Luc Montagnier to hunt for a virus in the new gay disease in the autumn of 1982. He began testing batches of human plasma for "reverse transcriptase activity", a biochemical sign indicating the possible presence of a retrovirus. (See page 46 of his book "Virus"). Montagnier's research eventually led to the first discovery of the AIDS virus at the Pasteur Institute in Paris.

Although the CDC and the New York Blood Center claimed it was safe, many health professionals refused the hepatitis B vaccine. In 1985, only 23 out of 162 Rhode Island dentists agreed to take the vaccine because of concerns about AIDS. As late as 1990, 13 out of 14 black nurses at a university hospital refused to take the vaccine for the same reason.

The fate of the gay men in the gay experiments

The purpose of the gay experiments was to test a vaccine that could immunize people against hepatitis B virus. Infection with this virus could lead to severe liver disease and sometimes to liver cancer. Ironically, an unprecedented explosion of cancer took place in male homosexuals after the experiment. Reports of the fate of these men attest to the fact that participating in the government's experiments was clearly injurious to the health of gay men.

Significantly, there were no reported blood specimens anywhere in the U.S. that were HIV-positive prior to the epidemic in 1979, except in the samples stored at the NYBC.
In a May 12, 1983, letter to the editor of The New England Journal of Medicine, Cladd Stevens (who supervised the NYBC experiment) wrote : "No cases haves occurred in the vaccine recipients from populations at low risk of AIDS, and there is no excess incidence in the high-risk population." But this proved to be incorrect in later reports co-authored by Stevens.

In a 1985 report Cladd Stevens et al. claimed that seven men (out of 1083) were HIV-positive before they received either vaccine or placebo. If true, this indicates that HIV (and possibly the KS virus) was already present in the blood of Manhattan homosexuals and could have contaminated the pooled blood of gays whose plasma was used to make the vaccine in 1977.

As stated previously, a 1986 report in JAMA showed 20% of the men in the experiment were already infected with HIV by the end of 1981; and by 1984, more than 40% of the men were HIV-positive and doomed to death.

Another follow-up study of 8,906 gay men who donated blood for the hepatitis experiments in Manhattan was released in 1992. Statistical analysis of this group showed that mortality rates for men aged 25-44 began to rise in the 1980s, with AIDS the leading cause of death among young men in New York City. Remarkably, "The all-cause mortality in this cohort in 1988 was 24 times higher that the mortality rate in the cohort before the beginning of the AIDS epidemic."

Was the hepatitis B vaccine contaminated with HIV and the KS virus?

Largely forgotten in AIDS history is the hepatitis B vaccine trial that also took place with 685 gay Dutch volunteers in Amsterdam between November 1980 and December 1981. Unlike the American vaccine makers, the Dutch researchers heated their experimental hepatitis B vaccine for added safety.

A 1986 report of the trial clearly states the AIDS virus "was not transmitted by the heat inactivated hepatitis B vaccine." Of the 685 participants, five were already infected with HIV when the trial began. The researchers theorized that HIV entered the Dutch gay population at the end of the 1970s.

Another follow-up Dutch report of this trial in 1993 again suggests the efficacy of heating the vaccine for safety. (The experimental vaccine was not heated in the U.S. until after all the gay experiments were completed.) At the end of 1982, one year after the Dutch experiment had ended, only As stated previously, a 1986 report in JAMA showed 20% of the men in the experiment were already infected with HIV by the end of 1981; and by 1984, more than 40% of the men were HIV-positive and doomed to death.

7.5% of the Amsterdam men were infected. In contrast, 26.8% of the men in the New York experiment were HIV-positive; and a whopping 42.6% of the San Francisco men were HIV-positive. These statistics showing many men infected in the American trials in 1982 further prove that Cladd Stevens of the NYBC, and the CDC, were incorrect in declaring there was no excess incidence of AIDS in the "high-risk" gay male population.
The fate of all the men who participated in the hepatitis B vaccine trials in six U.S cities has never been revealed. However, it is likely from the statistics presented in JAMA in 1986 that many, if not most, of the men eventually died of AIDS. The actual number of AIDS deaths has never been revealed, nor have the individual medical records been studied. Attempts to secure this information have been rebuffed by the Blood Center, due to the "confidential" nature of the experiment.

"Gay Cancer" and the origin of AIDS
After the introduction of HIV and the KS virus into the U.S. gay male population in the late 1970s, the incidence of KS skyrocketed.

A 1989 report by Biggar found no cases of KS in young men in New York City during the years 1973-1976. But by 1985 the incidence of KS in "never-married men" in Manhattan had increased 1850 times. In San Francisco the rate of KS increased over 2000 times!

KS is now 20,000 times more common in AIDS patients than in the general population. A 1985 autopsy study by Lee Moskowitz of 52 AIDS cases (23 Haitians, 19 gays, 5 intravenous drug abusers, 2 hemophiliacs, and 3 persons at unknown risk) showed that 94% of AIDS patients from the various risk groups had internal KS. The CDC claims KS now occurs in only 15% of gay men (down from 30% at the beginning of the epidemic), but these statistics are not based on current autopsy studies

KS was never a sexually-transmitted disease before the introduction of HIV into gays. For a century after the first reported KS cases were discovered in Vienna in 1872, there was no evidence that KS could be transmitted from person-to-person.

By 1950, a more aggressive "endemic" form of KS was uncovered in African blacks. Still, there was no evidence the disease was transmissible or contagious. Suddenly with the introduction of HIV into the homosexual community, scientists began to view KS as a contagious "gay cancer" out of Africa.

The new KS virus is closely related to a monkey tumor virus, known as herpes virus saimiri, that was extensively studied by researchers in the VCP in the decade before the epidemic. Initially found only in KS from AIDS patients, the new KS virus has also been found in non-AIDS-related KS tumors and in other forms of cancer, such as lymphoma and multiple myeloma.

HIV is a cancer-causing virus. Infection with HIV (with or without the KS virus) has resulted in a noticeable increase in various forms of cancer. A 2005 study of over 4000 AIDS patients showed higher rates of melanoma, basal and squamous cell skin carcinomas, anal carcinoma, prostate carcinoma, and Hodgkin disease, when compared with age-adjusted rates for the general United States population.

The KS virus is now in the U.S. blood supply; and blood is not screened routinely for this virus. A 2001 study indicated that 15% of normal Texas blood donors showed evidence of KS virus infection in the blood. A 2002 study of healthy children (ages 4-13) in South Texas showed that 26% had antibodies to the KS virus in their blood.

Is AIDS a man-made disease?

How did these two viruses of primate origin get into the gay male population to cause AIDS and a contagious form of cancer? AIDS experts blame monkeys and chimps in the African jungle. My research indicates it is much more likely these viruses were introduced during government-sponsored hepatitis B experiments using gays as unsuspecting guinea pigs. Extensive documentation of past "secret medical experiments" by the government can be found on Google. A recent BBC news report (30 Nov 2004) uncovering unauthorized and dangerous HIV drug experiments on infants and children in New York City orphanages can be found by Googling: BBC + guinea pig kids.
Until proven otherwise, a "new" HIV retrovirus and a "new" KS virus could easily have been developed in a laboratory as part of the Virus Cancer Program. In the decade before AIDS it was common to transfer and adapt primate retroviruses and herpes viruses into human cells in genetic engineering experiments. Such viruses were deemed potential "candidate human viruses," as clearly stated in the annual progress reports of the VCP. For further details on the relationship of the VCP to the introduction of HIV, Google: virus cancer program + AIDS.

The connection between the hepatitis experiments and the AIDS epidemic was quickly dismissed by government authorities two decades ago. However, it is clear from a review of the scientific literature that the "gay plague" began immediately after the government experiments; and the experiments permanently damaged the health of the gay community, and led to continuing spread of HIV into the "general population."

Are we to believe that all this is merely a coincidence -and that AIDS in America resulted simply from two viruses jumping species in the African jungle? Or is the origin of HIV and AIDS -and the KS virus- related to secret medical research and covert human testing, as suggested here.

[Dr. Alan Cantwell is a retired dermatologist; and the author of five books on the man-made origin of AIDS and the infectious origin of cancer, all published by Aries Rising Press, PO Box 29532, Los Angeles, CA 90029 ( Email: Abstracts of 30 published papers can be found at the PubMed website. Many of his personal writings can be found on by typing in key words "alan cantwell" + articles. His latest book is Four Women Against Cancer: Bacteria, Cancer and the Origin of Life. His books are available on and through Book Clearing House @ 1-800-431-1579]


Cantwell A. AIDS and the Doctor of Death: An inquiry into the origin of the AIDS epidemic. Aries Rising Press, Los Angeles, 1988.

Cantwell A: Queer Blood: The secret AIDS genocide plot. Aries Rising Press, Los Angeles, 1993.

Miller M.KS enters Y2K still riddled with many questions. J Natl Cancer Inst. 1999 Oct 6;91(19):1612-4.

Szmuness W. Large-scale efficacy trials of hepatitis B vaccines in the USA: baseline data and protocols. J Med Virol. 1979;4(4):327-40.

Szmuness W, Stevens CE, Harley EJ, Zang EA, Oleszko WR, William DC, Sadovsky R, Morrison JM, Kellner. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med. 1980 Oct 9;303(15):833-41.

Szmuness W, Stevens CE, Zang EA, Harley EJ, Kellner A.
A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report. Hepatology. 1981 Sep-Oct;1(5):377-85.

Yacovone JA, Weisfeld J. Acceptance of hepatitis B vaccine by Rhode Island dental practitioners. J Am Dent Assoc. 1985 Jul;111(1):65-7.

Spence MR, Dash GP. Hepatitis B: perceptions, knowledge and vaccine acceptance among registered nurses in high-risk occupations in a university hospital. Infect Control Hosp Epidemiol. 1990 Mar;11(3):129-33.

O'Brien TR, Kedes D, Ganem D, Macrae DR, Rosenberg PS, Molden J, Goedert JJ. Evidence for concurrent epidemics of human herpesvirus 8 and human immunodeficiency virus type 1 in US homosexual men: rates, risk factors, and relationship to Kaposi's sarcoma. J Infect Dis. 1999 Oct;180(4):1010-7.

Dollard SC, Nelson KE, Ness PM, Stambolis V, Kuehnert MJ, Pellett PE, Cannon MJ. Possible transmission of human herpesvirus-8 by blood transfusion in a historical United States cohort. Transfusion. 2005 Apr;45(4):463-5.

Sacks HS, Rose DN, Chalmers TC. Should the risk of acquired immunodeficiency syndrome deter hepatitis B vaccination? A decision analysis. JAMA. 1984 Dec 28;252(24):3375-7.

Stevens CE, Taylor PE, Zang EA, Morrison JM, Harley EJ, Rodriguez de Cordoba S, Bacino C, Ting RC, Bodner AJ, Sarngadharan MG, et al. Human T-cell lymphotropic virus type III infection in a cohort of homosexual men in New York City. JAMA. 1986 Apr 25;255(16):2167-72.

Stevens CE, Taylor PE, Rubinstein P, Ting RC, Bodner AJ, Sarngadharan MG, Gallo RC. Safety of the hepatitis B vaccine. N Engl J Med. 1985 Feb 7;312(6):375-6.

van Griensven GJ, Hessol NA, Koblin BA, Byers RH, O'Malley PM, Albercht-van Lent N, Buchbinder SP, Taylor PE, Stevens CE, Coutinho RA. Epidemiology of human immunodeficiency virus type 1 infection amonghomosexual men participating in hepatitis B vaccine trials in Amsterdam, New York City, and San Francisco, 1978-1990. Am J Epidemiol. 1993 Apr 15;137(8):909-15.

Biggar RJ, Burnett W, Mikl J, Nasca P. Cancer among New York men at risk of acquired immunodeficiency syndrome. Int J Cancer. 1989 Jun 15;43(6):979-85.

Moskowitz LB, Hensley GT, Gould EW, Weiss SD. Frequency and anatomic distribution of lymphadenopathic Kaposi's sarcoma in the acquired immunodeficiency syndrome: an autopsy series. Hum Pathol. 1985 May;16(5):447-56.

Barahona H, Melendez LV, Hunt RD, Daniel MD. The owl monkey (Aotus trivirgatus) as an animal model for viral diseases and oncologic studies. Lab Anim Sci. 1976 Dec;26(6 Pt 2):1104-12.

Koblin BA, Hessol NA, Zauber AG, Taylor PE, Buchbinder SP, Katz MH, Stevens CE. Increased incidence of cancer among homosexual men, New York City and San Francisco, 1978-1990. Am J Epidemiol. 1996 Nov 15;144(10):916-23.

Burgi A, Brodine S, Wegner S, Milazzo M, Wallace MR, Spooner K, Blazes DL, Agan BK, Armstrong A, Fraser S, Crum NF. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals. Cancer. 2005 Oct 1;104(7):1505-11.

Baillargeon J, Deng JH, Hettler E, Harrison C, Grady JJ, Korte LG, Alexander J, Montalvo E, Jenson HB, Gao SJ. Seroprevalence of Kaposi's sarcoma-associated herpesvirus infection among blood donors from Texas. Ann Epidemiol. 2001 Oct;11(7):512-8.

Baillargeon J, Leach CT, Deng JH, Gao SJ, Jenson HB. High prevalence of human herpesvirus 8 (HHV-8) infection in south Texas children. J Med Virol. 2002 Aug;67(4):542-8.

Site Admin
Posts: 7781

US Tries Desperately To Dismiss AIDS Origin Lawsuit

Post#3 » Mon Dec 19, 2005 7:37 am

US Tries Desperately To Dismiss AIDS Origin Lawsuit

SAN DIEGO -- Federal Judge Sabraw has ordered an open court oral argument for Friday, June 24, 2005 at hear arguments by the United States to support a motion to dismiss the AIDS ORIGIN lawsuit of Dr. Boyd Ed Graves. Dr. Graves AIDS ORIGIN research and his nearly eight years of continuous legal action against the United States for the creation, production and proliferation of HIV/AIDS has been receiving critical acclaim from scientists and medical doctors from all over the world.

"I am hopeful," said Graves, "that the Federal Court will deny the United States motion to dismiss and allow this issue to reach a jury verdict some time next year. I am certain reasonable people will conclude the U.S AIDS ORIGIN documents require and demand further accountability from the defendant, the United States of America."

According to the 1971 progress report of the U.S. Special Virus program, HIV/AIDS is a recombinant (virus) agent that has been formed by converging a leukemia and a lymphoma, a BIOLOGOCAL WEAPON.

In 1984, (alleged) co-discoverers of HIV/AIDS, Drs. Robert Gallo and Luc Montagne, concluded the original name of HIV/AIDS is LEUKEMIA/LYMPHOMA virus. See, Montagnue, L. & Gallo, R.C., et. al., Human T-Cell Leukemia Lymphoma Virus Cold Spring Harbor Laboratory, (Cold Spring Harbor, NY, 1984). Additionally, the United States admits that the Nazi sheep virus visna, had not yet appeared in human disease. Because no one could explain how this Nazi sheep virus supposedly hopped species, the U.S. General Accounting Office began an investigation into the U.S. origin of HIV/AIDS in July, 2001 at the bequest of a Congressman.

The United States has sought to hide, dispel, distract and mislead any serious inquiry into the U.S. Special Virus program at every level and by every means necessary until this litigation.

For the rest of the story go to:

Site Admin
Posts: 7781

Doc Makes Candid Comments on HIV Vaccine

Post#4 » Mon Dec 26, 2005 11:05 pm

Doc Makes Candid Comments on HIV Vaccine
By JOHN SOLOMON (Associated Press Writer)
From Associated Press
December 25, 2005 10:33 PM EST
WASHINGTON - In an unusually candid admission, the federal chief of AIDS research says he believes drug companies don't have an incentive to create a vaccine for the HIV and are likely to wait to profit from it after the government develops one.

And that means the government has had to spend more time focusing on the processes that drug companies ordinarily follow in developing new medicines and bringing them to market.

"We had to spend some time and energy paying attention to those aspects of development because the private side isn't picking it up," Dr. Edmund Tramont testified in a deposition in a recent employment lawsuit obtained by The Associated Press.

Tramont is head of the AIDS research division of the National Institutes of Health, and he predicted in his testimony that the government will eventually create a vaccine. He testified in July in the whistleblower case of Dr. Jonathan Fishbein.

"If we look at the vaccine, HIV vaccine, we're going to have an HIV vaccine. It's not going to be made by a company," Tramont said. "They're dropping out like flies because there's no real incentive for them to do it. We have to do it."

"They will eventually - if it works, they won't have to make that big investment. And they can make it and sell it and make a profit," he said.

An official of the group representing the country's major drug companies took sharp exception to Tramont's comments.

"That is simply not true. America's pharmaceutical research companies are firmly committed to HIV/AIDS vaccine research and development with 15 potential vaccines in development today," said Ken Johnson, senior vice president of PhRMA, the Pharmaceutical Research and Manufacturers of America.

"Vaccine research is crucial to controlling the AIDS pandemic and our companies are well aware of the need to succeed in this vital area of science," Johnson said.

In an e-mail response for comment, Tramont said the HIV vaccine mirrors the history of other vaccines. "It is not just a HIV vaccine - it's all vaccines - that is why there was/is a shortage of flu vaccines," Tramont wrote.

The quest for an AIDS vaccine has been one of science's biggest disappointments despite billions of dollars and years of research. Part of the dilemma is that such a vaccine must work through the very immune system that AIDS compromises.

The failure in the last couple years of one of the more promising vaccine candidates has bred some frustration.

The United Nations' top HIV/AIDS official acknowledged earlier this year at a conference that it was no longer realistic to hope that the world will meet its goal of halting and reversing the spread of the pandemic by 2015. A British delegate to that conference predicted it might take 20 years before such a vaccine is created.

The International AIDS Vaccines Initiative, a not-for-profit group that is pushing for an AIDS vaccine, said there are more than 30 vaccine candidates being tested mostly on a small scale in 19 counties, but it acknowledges many are pursuing a similar theory of science that may prove futile.

"If the hypothesis is proven incorrect, the pipeline of candidates now in trials will be rendered mostly irrelevant. Strong alternative hypotheses have been largely neglected," the group said.

IAVI estimates total annual spending on an AIDS vaccine is $682 million.

"This represents less than 1% of total spending on all health product development," IAVI said. "Private sector efforts amount to just $100 million annually. This is mainly due to the lack of incentives for the private sector to invest in an AIDS vaccine - the science is difficult, and the developing countries that need a vaccine most are least able to pay."


Editors; Associated Press Writer Randolph E Schmid contributed to this story.

Site Admin
Posts: 7781


Post#5 » Fri Jan 06, 2006 4:19 am


Category: News & Opinion (General) Topic: Government
Published: January 5, 2006 Author: By David Guyatt
For Education and Discussion Only. Not for Commercial Use.


By David Guyatt

AIDS kills. It does so in extremely nasty ways. By attacking the human immune system, the disease opens the victim to any number of, otherwise, non fatal illnesses. The result is generally a heart-rending debilitating and lingering death.

According to some experts, AIDS - Acquired Immune Deficiency Syndrome - first arose in the middle to late 1970’s in Africa, when a small, infected Green Monkey, sunk its teeth into a local native. From such humble beginnings it then exploded across the globe - as a result of sexual transmission - bringing massive death and misery in its wake.

There are currently 30 million people - throughout the world - who have contracted the killer disease. With a death toll already set at over 8.4 million, estimates indicate this could leap to 40 million by the year 2000. Over 1000 people are dying from AIDS per day. Figures provided by the United Nations show that the geographic spread is almost entirely focused on black Africa and Southeast Asia - which combined - account for almost 90% of all known cases. In effect, AIDS/HIV fundamentally attacks the impoverished Third World.

This geographic spread has led to spectacular charges that the rich industrialised countries secretly developed and deployed AIDS as a biological weapon aimed at decimating the “useless eaters” of the Third World. Researchers point to a number of government documents which they claim supports this charge. Chief amongst these is National Security Memorandum (NSSM 200) authored in the early seventies by then US National Security Adviser, Dr. Henry Kissinger. This document, hitherto marked as top secret, was quietly de-classified in 1990 and lodged in the US National Archives. It is a chilling, cynical document.

“De-population should be the highest priority of US foreign policy towards the Third World.” This sentence formed the hard backbone of NSSM 200. The memo went on to state that “Reduction of the rate of population in these States [Third World nations] is a matter of vital US national security.” Why? Simply because “The US economy will require large and increasing amounts of minerals from abroad, especially from less developed countries.” In stating this the focus was exclusively, on the “…economic interests of the US.”

The arrogant and cynical mindset that underscored Kissinger’s document was nothing new. Third World citizens merely continued to be viewed as useless, lazy degenerates. Years earlier, in 1932, cancer experiments were undertaken by Cornelius Rhoades, then chief pathologist of the Rockerfeller Institute. The experiments involved deliberately infecting a number of Puerto Ricans with cancer. Thirteen died as a consequence. Rhoades explained away the experiments with the comment: “The Porto(sic) Ricans are the dirtiest, laziest, most degenerate and thievesh race of men ever inhabiting this sphere… I have done my best to further the process of extermination by killing off eight and transplanting cancer into several more… all physicians take delight in the abuse and torture of the unfortunate subjects.”

Amazingly, Rhoades not only escaped prosecution for this hideous admission, but was later placed in charge of a number of chemical warfare projects during WW11. He was also given a seat on the Atomic Energy Commission and awarded the Legion of Merit. One may also remark on the known close connections of Henry Kissinger to the Rockerfeller family. It was due to this close family connection that Kissinger was appointed National Security Adviser in the Nixon administration in 1971. According to US News & World Report the appointment “was on the advice of Governor Rockerfeller, who described Mr. Kissinger as ‘the smartest guy available.’”

When viewed in conjunction with another US government document, the underlying foreign policy aims of NSSM 200, are cause for concern in the minds of many observers. During 1970, the US Department of Defence applied to the US Senate appropriations committee for funding to research and develop a biological weapon that would attack the human immune system. The request was for the development of “synthetic biological agents.” In giving testimony to the Senate committee, Dr. Donald MacArthur, a US Army biological warfare expert, stated: “Within the next 5 to 10 years, it would probably be possible to make a new infective micro-organism which could differ in certain important aspects from any known disease-causing organisms.” Dr. MacArthur then added “Most important of these is that it might be refractory to the immunological and therapeutic processes upon which we depend to maintain our relative freedom from infectious diseases.” He concluded that a feasibility research programme to this end “could be completed in approximately 5 years at a cost of $10 million.” The requested sum was granted.

Professor Jakob Segal and his wife Lilli both believe that AIDS was laboratory manufactured at Fort Detrick, Maryland - home of America’s Chemical and Biological Warfare programme. Segal, a Russian-born Professor of biology at Humboldt University in then East Germany stated that AIDS was the result of a US germ warfare programme. The couple published their findings in a 1986 pamphlet “AIDS: USA Home-Made Evil. The couple set about trying to show that the AIDS virus HIV is almost identical, in some regards, to two other viruses. These are Visna, a deadly disease that kills sheep, but is not infectious to humans, and HTLV-1 (Human T-Cell Leukemia Virus) which though not fatal is highly infectious to humans.

Segal then went on to state that the P4 High Security laboratory at Fort Detrick, was responsible for splicing both Visna and HTLV-1 together, thus creating an artificial biological weapon that was both highly infectious and deadly to humans. The result was HIV. Segal maintains this virus was finally created between late 1977 and the spring of 1978. Disparaging the then common view that AIDS had first arisen in Africa, Segal insisted that the Fort Detrick cocktail was tested on prison inmates who had volunteered to participate in experiments in exchange for their release. Because symptoms did not show up inside six months, the convicts were released according to the prior agreement. Since a number of them were gay, Segal claimed, they travelled to New York and unknowingly began infecting other members of New York’s gay community. From here the first known AIDS case appeared in 1979 and soon began spreading like wildfire.

Segal’s theory and chain of events are viewed by many medical experts as entirely fictitious. Others believe he was a willing instrument of a Soviet KGB disinformation campaign. As a result of these and other factors, leading medical journals refused to publish his theory and findings. Seeking to discover more detail, The X Factor spoke to a representative of Fort Detrick, Maryland. The spokesman confirmed that the conspiracy theory surrounding AIDS was a known KGB disinformation project. However, they also confirmed that they had worked on AIDS as part of a biological warfare programme. This, they said, resulted from the need to protect US military personnel posted to highly infectious regions of the world from being infected with the disease.

Despite this, Segal is not alone in suggesting that AIDS was the result of biological warfare experiments. Dr. William Campbell Douglas - a high profile American physician with a background in Aviation and Space medicine, and a former US Navy Flight Surgeon - also believes AIDS was man-made. Douglas couldn’t be politically further apart from the Segal’s. His rhetoric is noticeably right wing and he regards himself as a “dedicated anti-communist.” During a public lecture in August 1990, he admitted the KGB disinformation programme had caught him of guard. It was, he said, “…A clever psy-war ploy, which, for a while anyway, neutralised those of us who were saying essentially the same thing, that the AIDS virus was probably created through recombinant genetic engineering…”

Although left-footed for awhile, as he admits, the savvy Douglas soon found an acceptable riposte to the KGB disinformation conundrum. Soviet agents had penetrated and been working inside “our top security biological warfare laboratories for over 20 years,” Douglas claimed. To support his argument, Douglas refers to an article in Omni Magazine dated March 1986, which reportedly quotes Nobel Peace prize Winner, Dr. Carlton Gajdusek - an official at Fort Detrick. Gajdusek is reported as saying “In the facility I have a building where more good and loyal communists scientists from the USSR and mainland China work, with full passkeys to all the laboratories, than they are Americans.”

Douglas firmly believes that the irruption of AIDS began in Africa, but not as a result of a green monkey biting a local native. His theory is that the World Health Organisation surreptitiously infected the citizens of Africa with laboratory created AIDS concealed within their widespread smallpox vaccination project. Douglas admittedly subscribes to the conspiratorial view that the World Health Organisation was an evil instrument of the former Soviet Union. He is not alone in this regard. Many on the political right in America, view the various offshoots of the United Nations as a communist-backed conspiracy funded by the Rockerfellers - and their banking chums - in a bid to gain control of the world via the so-called New Work Order.

Possibly, the most enduring man-made AIDS theorist is American, Dr. Robert Strecker, M.D. Strecker firmly believes that AIDS was manufactured in a laboratory as a biological weapon. To back-up his argument, Strecker outlines the many hundreds of open-air biological warfare tests conducted on US citizens without their knowledge. The idea is to show that the government wouldn’t hesitate using such a weapon if the need arose. As an example, Strecker mentions the comments of Jay Clemenson, a world renowned epidemiologist. In 1975, Clemenson spoke before a meeting of cancer and leukaemia experts in Tokyo. Strecker quotes him as saying “We are in fact establishing conditions for a pandemic spread of an organic virus varying on the scale of influenza of 1918.” This flu epidemic resulted in millions of deaths.

Strecker also argues that a virtual armoury of biological weapons - not just AIDS - has been developed and are in use. Collectively, he says, these secret weapons are set to destroy mankind - or at least a significant part of it - once again evoking the fears of Third World slaughter. He also points to the massive outbreak of bovine leukaemia in Europe in the 1950’s - which led to the wholesale slaughter of cattle herds. The reference draws clear parallels with the recent outbreak of Mad Cow Disease.

Unsurprisingly, the future of biological weapons occupies the minds of military strategists. In a paper entitled “Twenty-First Century Germ Warfare” by USAF Lt. Colonel Robert P Kadlek, the author has this warning “Using biological weapons under the cover of an endemic or natural disease occurrence provides an attacker the potential for plausible denial.” He then continues “Biological warfare can include the use of Bacteria, Rickettsia, Viruses and Toxins to induce illness or death in humans, animals and plants.”

Whatever one may think or believe about AIDS as a biological weapon, the future clearly looks very bleak. Because of the inherent “deniability” of these weapons bio-wars could be fought without the public ever knowing about it. The only tell-tale sign will be more mass graves.

Third World Sterilisation & Birth Control - a Hidden Agenda?

The drug, Quinacrine, was widely used in third world mass sterilisation programmes - often concealed as “clinical trials.” Even though the World Health Organisation had warned the drug was unfit for humans, these trials continued with funding provided by private US foundations - concerned at the US “national security” threat of growing the third world population. Another drug, Norplant, was similarly used as a prolonged birth control vaccine in the poorest nations of the world. Surgically implanted beneath the skin, the drug caused serious health side effects. This led one health worker to bitterly state “It’s cheaper for them [America] to use Third World women than to use an animal in a laboratory in the west.”

Genetically Engineered Organisms tested in Secret

Gary Null, host of New York’s popular Radio Station WBAI-FM broadcast a series of programmes on biological warfare in 1993. Null revealed that the Wistar Institute - a US government funded organisation conducted secret field trials in Argentina on a new rabies virus vaccine. Without bothering to apply for Argentinean government approval, Wistar technicians inoculated cattle with a genetically altered recombinant DNA vaccine. This episode resulted in the infection of up to 17 farm workers, according to the Argentinean Minister of Health. The US government responded by stating that whilst it had funded the Wistar Institute it had not provided funds for the Argentinean trip.

The HIV Controversy - A Hoax that became a Scam

An increasing number of medical experts have attacked the theory that HIV causes AIDS. The most well known of these is Peter Duesberg, a Professor of Molecular Biology at the University of California. Duesberg, moreover, has attacked the AIDS drug AZT, saying it causes AIDS not cures it - “AIDS by prescription.” In an article in “Spin Magazine” in 1993, Duesberg said that HIV Positive patients prescribed AZT “lose weight, they become anaemic, they lose their white blood cells, they have nausea, they lose their muscles… and they die. …That what you call AIDS by prescription.” Duesberg, in addition, stated in his book “Inventing the AIDS Virus” that he was approached by an official of the National Institutes of Health who made him an “offer” in exchange for recanting his position on AIDS.

Site Admin
Posts: 7781

Role of bioengineering in CFS, GWS & AIDS CFS Radio Prog

Post#6 » Fri Jan 06, 2006 4:27 am

Role of bioengineering in CFS, GWS & AIDS CFS Radio Program
Dec. 19th, 1999
Roger G. Mazlen, M.D. Host
Donald W. Scott

Dr. Mazlen
Our guest is waiting from Canada and be with us shortly. We're going to be talking with Don W. Scott, the author of the Brucellosis Triangle. Interestingly enough, Donald Scott was our guest on the year end show in 1998. He was here on the show the 20th of December and we're here again at the year end show and we're going to follow up and it's going to be a really exciting and interesting follow-up. We're going about basically, infectious diseases for which our Chronic Fatigue Syndrome audience are particularly susceptible, most of them being significantly immunosuppressed and vulnerable to just about anything that's contagious that comes along. So they should be listening carefully. Now, we're going to talk about the West Nile Virus, which was present with us here in New York during the late summer. The West Nile Virus appeared in New York and then was found in Connecticut and New Jersey. It's mosquito-borne. It killed 7 people in those three states before the summer was over and it's been predicted, and I'm quoting from the New York Times in an article published on December 15th, they said "The virus would likely re-emerge next spring when mosquitoes come out of hibernation." This quote is from health experts testifying before the United States Senate. So, with that, we're going to kick off and talk to Donald W. Scott because he has some news for our listening audience about where this West Nile Virus may actually have come from. We're not saying we know it for sure, and we're not documenting it but we want to present you with some facts. Hi Donald, welcome to the show.

Don Scott
Good morning, it's nice to be here.

Dr. Mazlen
And I'd like you to tell our audience something about the information that you have from the Riegle Committee with regard to this West Nile Virus.

Don Scott
As you and many of your listeners will recall, when the West Nile Virus was first identified, official government sources said, "well this is very strange because there has never been any West Nile virus in continental United States that we ever knew of." However, if one turns to the Riegle Report which was authored and supervised in its compilation by Donald Riegle who was a senator from Michigan, one will find that on May 21st, 1985, the United States had a supply of West Nile virus in the United States and that they shipped a quantity of that to Suddam Hussein. And that was in 1985 so that Suddam could use it against Iran with whom Iraq, at that point, was at war. So, there was West Nile virus in the United States well before 1985. It was shipped in 1985. There are still stocks of such a virus in the United States and the possibilities are two as to where the current outbreak came from. 1. Either accidentally from local facilities such as Plum Island there was an inadvertent escape of the virus on the mosquitoes or other insects or, there is always the possibility that one of Suddam Hussein's agents returned to the United States and was able to release a quantity of West Nile virus.

Dr. Mazlen
Well, I hope everybody's listening because you all have Congressman and Senators and public officials that you might know and you might be able to ask them about this and ask them to inquire about where this West Nile virus went when it got to Iraq. One thing I want to point out, and Donald, you can listen to this because this was also recently in the newspaper in New York, it was in the New York Times on the 5th of December and it's a quote. It says, "The scientists at the Centers for Disease Control and Prevention in Atlanta using scientific techniques," I'm paraphrasing that, "have also independently determined that the West Nile virus found in New York is very close to one isolated in 1998 from a stork in Israel" which is not far from Iraq. So, we have another way that it could have come around and rejoined us here in the United States because for all we know Iraq found a way to get it into Israel with whom they have no friendly relations. In fact, they're still at war with Israel.

Don Scott
Yes, people who know the migrating patterns of birds can infect that particular type of bird and release it in such an area that they know its migratory pattern would be over a selected country and if your congressman or your senator says, "well, give us some proof" tell them to get out the Riegle Report, published by the Congressional Printing Office and turn to page 47 and check the date, May 21st, 1985 and they will see that lo and behold, West Nile virus was shipped from the United States to Iraq on that date.

Dr. Mazlen
And, of course, we don't even know whether or not is was possibly even used in the Gulf War which is another subject we'll be turning to shortly. I want to also point out, that you're the author of the book, the Brucellosis Triangle and so we're going to stop next at another agent, that was shipped to Iraq and you have evidence of that, also, which was the agent, brucella melitensis, and tell us about that, because we also sent that over there.

Don Scott
Yes, they did. Brucellosis was a disease known for thousands of years actually, but in 1942 Canada, the United States and Great Britain entered into a secret agreement to take the brucellosis bacteria and make it more contagious and more virulent and to weaponize it, make it such that it would do serious damage to an enemy and they came up with a variant which they had tested in a number of places in Canada, the United States and Britain as well as other countries and they had indeed weaponized brucellosis. And when Iraq was at war with Iran, and Iraq wanted biological weapons to use against Iran who was winning that war, the United States shipped a supply of brucella melitensis bio type I and bio type III from the American type culture collection in Rockville, Maryland. They shipped that to Iraq and said, here you go, let this stuff out over Iran, it won't kill all the civilians that you're targeting, but it will produce a disease known as chronic fatigue as well as several other serious symptoms. So, in the Riegle report, lo and behold, that our research was confirmed. Brucella melitensis was shipped to Iraq from the United States and that evidence is found on page 41 of the Riegle report.

Dr. Mazlen
Now, just a quick aside. It's labeled as a class 3 pathogen. I presume that means it's fairly detrimental.

Don Scott
Yes, that means it's disabling but not deadly.

Dr. Mazlen
OK, for the audience so that they get an idea of how they classify these things.

Don Scott
Yes, well Donald Riegle spelled it out on page 38 of his report when he said, brucella melitensis is bacteria which can cause chronic fatigue, loss of appetite, profuse sweating when at rest, pain in joints and muscles, insomnia, nausea and damage to major organs which includes the heart, the liver and so on. Now, not only are you describing Chronic Fatigue Syndrome with that description, you're also describing Gulf War Illness. In other words, Suddam Hussein used the brucella melitensis that had been shipped to him against the Desert Storm forces in the Desert Storm attack of 1991.

Dr. Mazlen
I just want to ask Donald, where do you want people to contact you about this topic or about your book, the Brucellosis Triangle?

Don Scott
They can reach me at Box 133, Station B, Sudbury, Canada, P3E 4N5. And for this particular show's listening audience, I would like to indicate that if they want a copy of the Brucellosis Triangle which details the development of the weaponized Brucellosis bacteria, they can send a $20 check to me, Don Scott, at the address given and that $20 check will get them the Brucellosis Triangle which is regularly $21.95, but I will put in, in addition, a copy of our new Journal of Degenerative Diseases which covers all of the neurodegenerative diseases and especially in a series on Chronic Fatigue Syndrome, and I will also put in 10 pages of documents on history from congressional records including the June 9th, 1969 congressional meeting that may get to speak about, NSSM 200 (National Security Study Memorandum 200) by Henry Kissinger and pages from the Riegle report, so they can see for themselves why this disease that has existed for thousands of years suddenly erupted in two forms, one disabling, Chronic Fatigue Syndrome, and one lethal as AIDS. $20 will get you that whole package because we want people to see this for themselves.

Dr. Mazlen
And I can understand your willingness to do this to get it out and it's appreciated. I want to stop you there because I want to talk to you about the reason why, as you had said to me, why the Desert Storm attack was halted after 100 hours of amazing progress against Iraqi forces. What happened there?

Don Scott
Well, when the Desert Storm attack was launched, they were, of course, going great guns. They would have been in Baghdad in another 12 hours, as everybody knows. However, there were a series of scud explosions, somewhere close to 24 scud explosions, which did not shower shrapnel down upon the Desert Storm forces, but instead seemed to emit nothing but kind of a blue haze. Well, those scud missiles, plain and simply were armed with brucella melitensis as well as some other toxic agents. Now the other toxic agents included mustard gas, for example. They weren't trying to kill anybody with the mustard gas, they just wanted to make sure that the people being attacked knew they were being attacked. The people in the intelligence branch knew immediately from the 14,000 biological alarms that went off all up and down the front that they were being hit by brucella melitensis and they knew that thousands of veterans in the Desert Storm would become ill with Gulf War Illness. However, they also knew something else. They knew that back in 1985 and on other dates, the United States had not only provided brucella melitensis to the Iraqis, they had also provided anthrax. There were several shipments of anthrax to Iraq for use against Iran and the allied intelligence forces knew that when this melitensis attack occurred, the next volley of scuds would be armed with anthrax unless Desert Storm stopped dead in it's tracks, and George Bush new this. He phoned Schwartzkof in the middle of the night and he said "stop where you are," and Schwartzkof--we've got this in news accounts from the period--said "why is that Bob, things are going great," and George Bush said "I can't talk to you about it now, but stop where you are, don't move another foot," and Desert Storm stopped short of Baghdad, left Suddam Hussein in power because if they didn't stop, the next volley of scud missiles would be armed with anthrax and at 10% fatality rate there would be 70,000 dead allied troops on the desert within the next week. They stopped Desert Storm dead in its tracks, they began to withdraw two weeks later, Suddam Hussein is still in power and the leaders of most of the allied countries are out of power.

Dr. Mazlen
Well, that's a certainly striking story and we'd love to hear more about the documents or the information as to the phone call, as to what information Bush had gotten from national or military security sources. We just have a few minutes here but we need to cover a couple of quick important topics because mycoplasma are found in between 40 to 60% of Chronic Fatigue Syndrome patients and Gulf War patients as well have a huge prevalence of it. Where's the connection here and how does it relate to cancer, Don?

Don Scott
The mycoplasma is, as you know, a fragment of bacterial DNA and this particular fragment varies with the bacteria from which it was derived. The National Academy of Science, in 1995 in Washington, D.C. received a presentation from a group of top line microbiologists who had by experiment determined that there is a linkage between the mycoplasma fermentans incognitus strain and cancer. Now, we did not know of this, even though it was back in 1995, the report was made at that time, but for some reason or other mainstream medicine and the National Institutes of Health and so on do not seem to have done very much to make it common knowledge. Now, we have secured, as anybody can secure, and we will provide a copy if you want to write to us--they'd have to pay the cost of copying--but we have secured a copy of the report that clearly links or suggest very strongly that there's a linkage between the mycoplasma fermentans incognitus and cancer. That was the National Academy of Science, Washington, D.C., 1995.

Dr. Mazlen
That's startling and very important. Just quickly, what is the story in terms of the AIDS virus as you see it?

Don Scott
Well on June, 9th, 1969 Dr. Donald McArthur of Pentagon Biological Warfare research branch spoke to several congressmen in a top secret meeting and he told those congressmen if they voted him an additional 10 million dollars, the Pentagon would have within a 10 year period a new microorganism, one which does not naturally exist and for which, these are his words "no immunity could have been acquired." In other words, he promised the congressmen that if you give us 10 million dollars and 10 years we will give you the AIDS virus and you will be able to use that AIDS virus in strategic warfare, which means such things as reducing the population of certain target countries and that is in the hearings of June 9th, 1969 and that page is one of the pages that I will provide to anybody that wants to send me the $20 for the Brucellosis Triangle. I'll send them that page and I'll send them other relevant pages so they can see for themselves that AIDS and Chronic Fatigue Syndrome were both diseases that were engineered in biological warfare research laboratories. There's no doubt when you read these documents, which are government documents, achieved under freedom of information.

Dr. Mazlen
OK, now one quick thing. On our last show we mentioned about the mosquitoes that were raised and infected. Just very quickly how many mosquitoes were raised back when this happened and infected with these biological agents?

Don Scott
Yes, the Canadian government agreed to cooperate with the American government, and in Belleville, Ontario, the dominion parasite laboratory back in the 1950's and 1960's and into the 80's the dominion parasite laboratory raised 100 million mosquitoes a month which were transferred to certain universities to be contaminated with certain disease agents such as the disease agent that causes Chronic Fatigue Syndrome and these were then let out in a controlled way in certain communities so the the community could be studied to see how effective the mosquito was as a vector.

Transcribed by

Carolyn Viviani

Permission is given to repost, copy and distribute this transcript as long as my name is not removed from it.

© 1999 Roger G. Mazlen, M.D.

Site Admin
Posts: 7781

amazing Nairobi prostitutes whose immunity to HIV

Post#7 » Sun Jan 08, 2006 8:47 am

Sex slaves for science? ... andHealth/

Source: Globe and Mail
Published: January 7, 2005 Author: STEPHANIE NOLEN
For Education and Discussion Only. Not for Commercial Use.

Sex slaves for science?

Salome Simon has slept with almost 50,000 men since Canadian-led researchers discovered she's one of those amazing Nairobi prostitutes whose immunity to HIV could be the key to beating AIDS. Two decades later, with no cure in sight, she's still a medical guinea pig but also a grandmother who is tired of plying her trade. Canada, she tells Stephanie Nolen, should help her find a decent job

Saturday, January 7, 2006 Posted at 3:40 AM EST
From Saturday's Globe and Mail

NAIROBI — Salome Simon doesn't have much. A one-room shack she rents in Majengo, a slum on the edge of Nairobi. A couple of kangas, the bright print wraps she wears as skirts, and a couple of blouses. A transistor radio, some aluminum pots and one little luxury, a gilded bottle of spicy perfume.

It isn't much to show for 23 years of hard work, on the job from 7 in the morning to 7 in the evening, every day but Sunday, when she goes to church, and once a year when she visits her family in Tanzania for a few weeks. She doesn't have a house of her own, doesn't have any savings, doesn't have a plot of land to grow maize or beans.

There is one other thing that Ms. Simon doesn't have: AIDS.

And this sets her apart from the thousands of other women who make a living as she does, selling sex in Nairobi.

She has had sex with five or six men a day -- sometimes 10 or 11 on a really good day -- since she moved to Nairobi in 1982. Through those years, women have sickened and died all around her: Her own daughter succumbed to AIDS last year. Yet Ms. Simon remains bizarrely -- miraculously, she says -- free of the virus.

"I can't explain anything; it's only God who could," she says, erupting in a belly laugh that makes her stout body quiver. She doesn't know why she doesn't have AIDS, when the infection rate among commercial sex workers is estimated to be as high as 80 per cent in these slums.

No one else knows why she doesn't have HIV-AIDS, either. But that's not for lack of trying.

Ms. Simon, now 44, was one of a small group of women identified, and made famous, by researchers from the University of Manitoba in 1990. At the time, the discovery of women apparently immune to HIV seemed to herald, at last, a solution to the AIDS pandemic.

It was a huge discovery -- but the clues that lie in the cells of Ms. Simon and few dozen other women remain stubbornly elusive. Hundreds of thousands of dollars and years and years of research later, an estimated 40 million people have been infected with HIV and more than three million more have died of the disease since 1990, but neither the Manitobans nor the scientists around the world who have joined their hunt have been able to extract the miracle in Ms. Simon, and turn it into either a vaccine or the thing that few AIDS researchers even mention any more: a cure.

This story begins not with AIDS but with an outbreak of a nasty venereal disease called chancroid, which causes suppurating ulcers on the genitals. It flared up in Winnipeg in the late 1970s, and a few infectious-disease experts at the University of Manitoba began to investigate. Before long, they had figured out how to grow the bacteria that causes chancroid in the lab -- but the outbreak had been brought under control, and they were left without patients.

There it might have ended, had a Manitoba researcher not been talking to a colleague from the University of Nairobi at a conference a few months later. "You want chancroid?" the Kenyan asked. "Have we got chancroid. Come on over."

So they did, launching a scientific relationship that has lasted more than 25 years and led to some key findings in a global pandemic that was, even then, brewing in Kenya.

The first Manitoban to go to Nairobi was microbiologist Allan Ronald, who now works in Uganda. He arrived in 1980 and quickly noticed that there was no shortage of other diseases endemic in the area -- sexually transmitted infections such as chlamydia and gonorrhea were rampant. He also noticed that the people seeking help at clinics for these infections all frequented prostitutes.

So the Canadian researchers set up shop in Majengo, an industrial slum on the edge of the city and the site of the world's biggest market for mitumba -- second-hand clothes. With traders from all over East Africa coming to hunt for bargains among the bales of First World castoffs, the market is a magnet for trade, complete with food stalls, tearooms and hostels for the travellers. It's also a natural centre for sex work.

In the crowded alleys, where sewage runs in concrete drainage ditches, there is a warren of little mud-brick houses, their roofs made of sheets of zinc. Each contains just a bed -- a good hard bed, the owners will explain, because on a soft one all those puffing, pumping men can give you bruises. The travellers stop in here, and so do plenty of local residents -- police officers, civil servants, welders, street sweepers, teachers and taxi drivers pay 50 shillings (80 cents) for an encounter with Ms. Simon or one of her many colleagues.

"The men were travelling to that community to have sex, but the prostitutes weren't moving around, they lived in their own houses -- so the team established a clinic in the middle of the community to start studying the epidemiology," says Joanne Embree, a pediatrician and Nairobi veteran who heads the University of Manitoba's department of medical microbiology and infectious disease.

In those first few years, the Manitobans did some important research on sexually transmitted diseases, and the impact on children whose mothers were infected with gonorrhea or chlamydia. But the discovery that would rock the scientific world came not in the large and carefully monitored studies, but on the whim of a grad student.

Joan Kreiss, an infectious-disease fellow from the University of Washington, joined the project and decided to test blood samples from the sex workers for HIV. Her colleagues were skeptical (at the time, the disease was linked almost entirely to gay men in North America) and no one was prepared for the results: Well before Kenya had its first documented case of AIDS, 65 per cent of the women tested had been infected with HIV.

The news did not go over well: The government of Kenya threatened to deport the Canadians and shut down the whole project. "The government said, 'It's not true what you are saying! You're going to drive the tourists out!' " recalls Elizabeth Ngugi, a community-health professor at the University of Nairobi who has been a key member of the project since it began.

The Canadians rode out the storm, research on the Majengo women began in earnest and, in the next few years, the Manitoba-Nairobi partnership yielded two major discoveries.

The first was that mothers pass HIV to their babies in breast milk. Researchers already suspected some transmission this way, but Dr. Embree and a colleague showed that the longer a mother breastfed, the higher was the risk of transmission -- up to 44 per cent if she nursed for more than a year.

The second big discovery was that a person with a conventional sexually transmitted infection such as syphilis has a much higher chance of being infected with HIV -- as much as 70 per cent higher. The implications were stark for communities such as Majengo, where syphilis was rife.

But the discovery of the HIV-resistant women is what truly rocked the world of infectious disease.

Frank Plummer is one of Canada's better-known scientists; as director of the Centre for Infectious Disease Prevention and Control in Ottawa, he is the point man on everything from SARS to West Nile to that scary fever a tourist from Africa develops that may just be Ebola. But as a student in the early 1980s, he did some research with the Majengo project, and was "stunned" when he heard in 1985 that two-thirds of the women there were already HIV-positive.

"It was something totally out of the blue," he recalls. When he was in Kenya, he says, "we had no people who were sick with AIDS; it wasn't visible in our study. The initial enrolment . . . were all healthy."

There was little inkling at the time that there was any serious presence of AIDS in Africa, and the virus was believed rarely to be transmitted in heterosexual encounters, and difficult for women to catch. "So we asked a question: How did 65 per cent of these women get infected?"

Dr. Plummer moved back to Nairobi to immerse himself in the issue, and by 1988 he had noticed something bizarre about the prostitutes: Many were sick, but many more were still testing negative, and he concluded that a small number of the women -- perhaps 5 per cent -- were, he says, "basically immune to HIV. Their immune systems for whatever reason are able to recognize and kill" the virus.

"We did the models and found that these women were not just really, really lucky -- it was beyond the statistical chance of luck playing a role," says Keith Fowke, now a professor of medical microbiology in Winnipeg and then a student working under Dr. Plummer. "We estimate that many of these women have had 500 to 2,000 sexual exposures to infected men when they weren't using a condom."

Even more bizarre, the longer a woman had been selling sex, the less likely she was to be infected.

These findings were so strange that Dr. Plummer and his team couldn't get them published until 1990, and even then it wasn't until an international AIDS conference in Amsterdam in 1993 that the implications were widely appreciated.

He now believes there are pockets of HIV-resistant people all over the world, but few provide the obvious opportunity for study that these women do because of the fact that they are steadily exposed and still resistant.

When Dr. Plummer and his team honed in on the biological workings in the resistant women's bodies, things got even more interesting: "We looked for antibodies, and there were none."

So something else was going on.

"We started looking at their immune system," Dr. Fowke says. "HIV was able to establish initial infection and the immune system was able to clear it . . . We've really found cells that can kill HIV in these women."

Those, of course, are magic words: In 1982, the government of then-president Ronald Reagan declared that the solution to the new AIDS threat was a vaccine, and U.S. scientists hoped to have one ready within a year or two. More than two decades later, the target is still at least another 10 years away.

HIV has proved to be a fiendishly clever virus, one that thwarts most of the conventional approaches in vaccinology. But if these women could somehow kill off the virus, harnessing the source of their immunity could allow frustrated vaccine researchers to trigger the same mysterious process in other people.

Soon a team from Oxford University was at work: It figured out which portions of the virus were being recognized by the women's immune cells and then knit them together as a potential vaccine. But the results were so disappointing that it never reached a large-scale test, and so it was back to the drawing board for the Manitobans and their Kenyan partners.

"The model we're working on now," Dr. Fowke says of the resistance women, "is that they have some sort of natural vaccination -- either they were exposed to a virus that was defective that served as a vaccine, or they were initially infected and the immune system cleared it."

Even with the vaccine still on the horizon, the research from Majengo has been of huge value to medical science -- and yet it's surrounded by a rising wave of tension.

The two universities clearly have benefited from their partnership. Many young Kenyan researchers studied in Winnipeg. "Now, we have a pool of people who have been very well trained in the West," says Walter Jaoko, head of microbiology at the University of Nairobi, "but we don't have the facilities."

That soon will change with a $3.8-million, state-of-the-art research laboratory being built on the campus with a grant from the Canada Foundation for Innovation.

At the same time, the Canadian researchers had opportunities they would never have had at home. ("It's been incredible for us," Prof. Embree says.) And many -- most notably, Dr. Plummer, now scientific director of the National Microbiology Laboratory in Winnipeg as well as the nation's chief infectious-disease expert -- have made major names for themselves.

And through the years, millions of dollars in research money have moved through this project, about $23-million handled by the University of Manitoba alone. There have been grants from Canada's Medical Research Council, the Rockefeller Foundation, the European Economic Council, Britain's Wellcome Trust, the International Development Research Centre in Ottawa. Last June, Dr. Plummer and his team won a coveted Challenge Grant for $9.2-million from the Bill and Melinda Gates Foundation.

All those millions, and yet Ms. Simon -- a participant since the research began and now one of just two original participants known to be HIV-free -- still has sex for 80 cents in a fly-filled, mud-walled room. (In the past four years, only 20 of the 500 women who originally enrolled in the study in 1984 have been seen at the clinic, and 18 of them are now HIV-positive.)

In exchange for taking part in the research, all the Majengo women receive free basic health care and counselling. Since the start of last year, those with fully developed AIDS also receive free antiretroviral medication, which can keep an infected person alive and healthy for decades. But this is no perk. The drugs are supplied by the U.S. President's Emergency Plan for AIDS Relief, and are now free to all Kenyans.

Why did the medicine take so long? "Until a few years ago, when the prices came down, it was unimaginable," says Larry Gelmon, who co-ordinates the project for the University of Manitoba. "We were sorry about it and conscious of the need but . . . this project for years has been working on a shoestring and funds were unavailable."

As well, the researchers hold annual meetings where they try to gather the women and explain what they are working on. But a quick survey of the women in the clinic's waiting room on a bustling morning yields not one who says she understands what is being done with the blood she donates.

This, says the clinic's primary-care doctor, shouldn't come as a surprise. "At some point," Charles Wachichi explains, "you realize that these women are resigned to having to struggle for their existence -- they don't give a lot of thought to their special status. They just wake up and struggle for their daily bread. . . . The novelty tends to be sort of lost."

It's certainly lost on Ms. Simon, who says she has no idea why she is like she is -- only that it's of great interest to the Canadians. She came here from Bukoba in Tanzania in 1982 after her husband deserted her and their three small children. "There was nothing else I could do to get money so quickly -- I needed money to keep my family."

Now 44, she has small grandchildren, but still plies her trade -- as many as 50,000 men since joining the project -- and hates it.

"Get me a job and I'd leave Majengo," she says quickly. "But my education level is very low, it's not enough, and I have no skills. If I had the money, I'd start a business and leave this work."

But she earns so little, she says, that there is never enough left, once the rent is paid, food bought and school fees for her grandchildren sent home to Tanzania, to start saving for a kanga stall or fruit stand. A decade ago, she sold shoes for two years in the market, but the business failed. "And when it did, I had nothing else to do but go back to prostitution."

And so, while she is grateful for the prompt, free service at the clinic, she feels that she has been on the losing end of this partnership with the Manitobans.

"I feel they take advantage of me, because I've made such a big name all over the world [for the project], but I'm still in this business.

"I need something to lift me out of Majengo."

Her frustration is echoed by the Kenyan nurses and counsellors at the little clinic. "These women, 20 years later, they're still in these small rooms," one irate staffer says, adding that she and her colleagues suspect the researchers privately want the women to keep working: "With no sex workers, what would happen to their research?"

According to Prof. Ngugi, who has worked intimately with the women for 20 years, "this has given the world such a huge body of knowledge, but what has the world done to help them change? . . . Quite clearly there is an imbalance."

A few years back, a grant from the Canadian International Development Agency allowed her to train 120 of the women so they could leave prostitution behind. Two-thirds made the transition, she says, and many others would have, but died of AIDS first.

Now, researchers such as Larry Gelmon argue that there's little more they can do. "To be totally crass," he says, "it would be in our interest not to counsel them or give them condoms -- it's good for us, the more transmission there is."

And it isn't easy to offer a prostitute a worthwhile option, he says. "Most women in studies say they wouldn't do it if they didn't have to. But if they could earn 1,000 shillings a day from sex work or 400 from a fruit stand, they say, 'I'm going to go where the money is.' "

Dr. Plummer agrees that the women should be offered a way out. "I don't know what those ways out are, though, and anything we could do is just working on the margins. It's unlikely we'll be able to do anything to get them to the point that they're not partially dependent on sex work: You only make so much money selling tomatoes or weaving baskets."

In his cramped university office, Dr. Jaoko bristles at the suggestion that Ms. Simon and the other women have been exploited. "It's unfair to compare people's scientific progress with the life of women in Majengo. We give them services they would not get anywhere else. . . . They're there of their own volition. If they felt ill-treated, they would always leave . . .

"We're a scientific group and not a charity. It's not a personal gain; it's an international gain. We're looking at innovative ways to develop a vaccine which will benefit globally. And you can't say any research group has done research and lifted up an entire community. It doesn't happen -- ever."

Finally, he says, any source of research grants handed "a funding proposal saying you were going to spend the money on training for women . . . wouldn't accept it."

There is no question the project has had enormous impact. Despite her criticism, Elizabeth Ngugi is the first to say so.

"From my perspective, if I did not get involved with the Canadian university, the impact of HIV-AIDS on this country would have been much greater -- I'm not just saying that, the facts are there. We distributed the largest number of condoms in the country: Seven million condoms is not a joke."

It was Prof. Ngugi, then a nurse taking an extra course, who launched the outreach work that established this project. She began by tromping through Majengo, right up to Ms. Simon and the other women as they sat on three-legged stools outside their rooms waiting for customers. "I walked in the mud and in the sun and in the rain and in the dust," she says, shaking her head as she remembers teaching the women that sexually transmitted diseases really could be treated and inviting them to the clinic.

Hers was the first medical team anywhere, she says, to try to organize prostitutes directly. "And we got them to 80-per-cent condom use after the first year."

Kenyan men detest condoms, she explains, but she was able to persuade the sex workers that by presenting a united front, they could demand that clients use them. "If you are all saying, 'No sex without a condom,' where will these men go?"

Even today, many members of Nairobi's academic establishment flinch at the idea of working with prostitutes. Dr. Ngugi clearly adores them -- interested in their well-being as much as intrigued by the scientific challenge they present. She has received $17-million over the past 16 years from CIDA to fight AIDS and to establish a regional training network to share the discoveries made in Nairobi.

In Majengo, there are the immediate benefits, including the dramatic drop in chlamydia and gonorrhea, once endemic and now rare, and the longer-term payoff from simply having a better understanding of HIV. (Right now, University of Manitoba researcher Stephen Moses is doing a major study on the role of male circumcision in lowering the risk of infection.)

The project has also identified a group of women who are "non-progressors," or HIV controllers. They have been infected for more than 15 years but not progressed to fully developed AIDS. Their immune systems, too, offer hope of a new response to the disease.

Dr. Plummer says the team now knows several different genes are involved in whatever protects the resistant women, and by tracking family members, it has "good evidence" that resistance runs in families. Relatives of HIV-resistant women are about half as likely to be infected as someone who isn't related, "so we're going to do a whole genome analysis," he says.

But there is one grim -- and peculiar -- twist to the immunity: "The resistance is not absolute," Dr. Fowke explains. "So, occasionally, some women that we call resistant to infection do become infected."

What's peculiar is the apparent common denominator to all the women to whom this happens: Despite eight to 10 years of resistance, they're suddenly infected after taking a break from the job that supposedly endangers them.

"We believe their immune system is protecting them somehow," Dr. Fowke says, "but when they go on a break, that immunity is fading, and when they come back, we see HIV almost right away. Our hypothesis is that their immune system isnot fully ramped up."

As a result, all women who do take a break, such as Ms. Simon's trips home to Tanzania, are asked for blood samples before they go and when they come back, so he can measure any difference in immune response.

Baffling wrinkles like this make Dr. Fowke admit that sometimes an AIDS vaccine "feels impossibly far away. . . . We know more about HIV than any other pathogen at all, yet we still can't get a vaccine that is protective. All our knowledge about these HIV-resistant people is interesting and I feel it's important, but it's still a long way off from a vaccine. And that's frustrating."

Then again, "one of the things that I'm proudest of in our work is, we haven't cured AIDS in any way, but what we did is change people's thinking. Up until then, if people wanted to understand HIV, they were studying people who were infected . . . and in this case, we're studying people who are an immune success story."

Now, the Manitoba team's strategy is, in essence, to identify all the things that are different in these women's bodies, and then see if one of them is what neutralizes HIV. So far, no one factor is found in all of the women, so it appears likely that there many overlapping traits, including some that are genetic.

"The thing that makes this group exciting," Dr. Fowke says, "is that the answer is already there and we're looking for it -- we're not trying to find out if it exists."

Prof. Ngugi shares his excitement, but only so far. "It's fascinating, but also sometimes I feel very sad," she says, thinking of the women of Majengo. "Sometimes you are not a scientist but a friend, and you feel the emptiness inside."

For her, Salome Simon notes, pointedly, it will take more than free drugs or even a vaccine to make the emptiness go away.

After all, she's immune to AIDS.

rusalka writes: "Long but interesting read."

Site Admin
Posts: 7781

'Gay Cancer -GAIDS' And The Man-Made Origin Of AIDS

Post#8 » Tue May 23, 2006 12:24 am

'Gay Cancer' And The Man-Made Origin Of AIDS
By Dr. Alan Cantwell, MD
A Rense World Exclusive
©2006 Alan Cantwell, M.D

Twenty-five years ago in June 1981 a new epidemic of transmissible cancer, in the form of Kaposi's sarcoma, was uncovered in young gay American men with acquired immune deficiency disease (AIDS). In 1984 the cause of the AIDS was determined to be a new virus called HIV (the human immunodeficiency virus), now considered to be "the sole cause of AIDS."

A decade later, in 1994, yet another "new virus" was claimed as the cause of Kaposi's sarcoma (KS), the so-called "gay cancer" of AIDS. KS skin tumors were the hallmark of the "gay-related immune deficiency syndrome" when it first appeared in male homosexuals in Manhattan in the late 1970s. After a quarter century the precise origin of HIV, as well as the origin of the KS epidemic, remains mysterious.

With the discovery of the KS virus, it is now clear that two new viruses were introduced to produce what was initially regarded as the "gay plague". How were two new viruses (HIV and the KS virus) simultaneously "introduced" into gays to produce AIDS?

The origin of Kaposi's Sarcoma
Before the epidemic, KS was a rare cancer in the U.S. The KS virus -now called the human herpes-8 virus (HHV-8) or the Kaposi's sarcoma herpes virus (KSHV)- is now widely accepted as the cause of most cases of KS.

KS was first described in 1872 in Vienna, by Hungarian dermatologist Moriz Kaposi. Before the epidemic KS was a rare and usually mild form of cancer occasionally tumors in elderly Jewish and Italian-American men. The cancer was never considered a contagious, infectious, or sexually transmitted disease. KS in African-Americans was as rare as hen's teeth before AIDS appeared in the late 1970s.

In the 1960s KS was recognized as a common tumor in blacks in Central Africa. However, the African form of KS was not associated with the severe immunodeficiency characteristic of AIDS, nor was it sexually transmissible, and HIV was not found in these patients.

KS is a medical enigma. [1] How did KS become a transmissible epidemic disease in gays? How did the KS herpes virus escape detection during the first 15 years of the epidemic? Why did the KS virus and HIV suddenly appear together in the late 1970s to produce a "gay-related immunodeficiency disease?" How could cancer be "gay"?

Were these two simultaneous epidemics in gay men simply caused by two viruses out of the African jungle? Or was the hand of man - in the form of medical experimentation - responsible for the "introduction" of these viruses into the male homosexual community?

The two epidemics of AIDS and Kaposi's sarcoma

At the beginning of the epidemic many virologists thought KS might be caused by a transmissible herpes virus called the cytomegalovirus (CMV), which purportedly was found in the semen of gay men. However, when Robert Gallo of the National Cancer Institute discovered HIV in April 1984, interest in CMV waned.

After the KS virus was discovered in 1994, it was also found in other forms of cancer, such as lymphoma and multiple myeloma.

KS virus infection is no longer rare; and most people infected with the virus will never develop KS cancer tumors. However, when people are infected with HIV and the KS virus, KS tumors can occur. The KS herpes virus is considered a "helper virus," which encourages the development of KS cancer in HIV-infected people.

Researchers are still not exactly sure how the KS virus is transmitted. Mouth-to-mouth transmission, such as kissing, is believed to be the primary mode of spread. But kissing is hardly limited to homosexuals. Some studies have found the virus in the semen of KS patients, while other studies have not confirmed this. In Central Africa, where KS is endemic, children can become infected with the KS virus early in life before sexual activity occurs.

When AIDS began it was thought that "gay cancer" was similar to the more severe endemic form of KS found in Africa. However, as noted, African KS cases were HIV-negative and were not immunosuppressed. Some investigators have attempted to uncover the origin of AIDS by re-examining "old cases" of African KS. But AIDS, by definition, must be infection with HIV. Therefore, pre-AIDS KS cases have no connection to the origin of AIDS.

The epidemic of "Gay Cancer" exclusively in homosexuals

After the introduction of HIV and the KS virus into the U.S. gay male population in the late 1970s, the incidence of KS skyrocketed.

A 1989 report by Biggar et al. found no cases of KS in young men in New York City during the years 1973-1976. However, by 1985 the incidence of KS in "never-married men" in Manhattan had increased 1850 times; and in San Francisco the rate of KS increased over 2000 times! [2]

KS is now 20,000 times more common in AIDS patients than in the general population. Currently, the CDC claims that KS occurs in only 15% of gay men with AIDS (down from 30% at the beginning of the epidemic).
Separating the HIV epidemic from the KS epidemic

When stored blood samples of gays followed for HIV infection were re-examined by epidemiologists in 1999, it was reported that more than 20% of a group of 245 homosexual men from New York were infected with the KS herpes virus as early as 1982. [3]

Some experts now claim the epidemic of KS in gay men arose separately from the epidemic of HIV; and KS is thought to be an unrelated and distinct epidemic. However, the vital question of how two new viruses (HIV and the KS virus) were introduced exclusively and simultaneously into homosexual men is never raised. It is simply theorized that both the KS virus and HIV are "ancestor viruses" of primates in the African bush that jumped species to infect the human population.

The Virus Cancer Program and biological warfare research

In the decade before AIDS, animal retroviruses (similar to HIV) and herpes viruses (similar to the KS virus) were extensively transferred between animal species as part of the Virus Cancer Program (1968-1980). The annual "Progress Reports" of the VCP details the animal cancer research and the genetic engineering of animal viruses.

In 1969 a military biowarfare expert predicted to U.S congressmen that a biological agent could be developed within a decade that would have a devastating effect on the human immune system and for which there would be no effective treatment. (For details Google: "Donald M MacArthur " + congressional testimony.)

Military biological warfare research became officially connected to VCP research on October 18, 1971, when President Richard Nixon permanently joined the Army's biowarfare research laboratory at Fort Detrick, Maryland, with the National Cancer Institute. The army lab was renamed the Frederick Cancer Research Center.
Scientists in the VCP wanted to learn how to use animal viruses to make cancer - and how to force "normal" human cells to become cancerous by subjecting them to various animal viruses. A primary task was the large scale production of cancer-causing viruses and suspected cancer viruses to meet research VCP needs on a continuing basis. Special attention was given to primate viruses (the alleged African source of HIV and the KS virus). Another goal was the production of "human candidate viruses." Candidate viruses were defined as animal or human viruses that might cause cancer in humans.

Biowarfare scientists had a keen interest in animal herpes "helper viruses" (1978 VCP Report;p 54). Chimps (who purportedly carry the ancestor virus of HIV) were extensively used by the VCP because there would be no official testing of cancer viruses on humans.

As biowarfare expert MacArthur predicted, the VCP created new cancer-causing viruses which had a deadly effect on the immune system. In one experiment recorded in the 1973 Report (p169), and later published in Cancer Research in 1974, newborn chimps were taken away from their mothers at birth and weaned on milk from cancer virus-infected cows. Essentially "AIDS" was created in animals. Some of the chimps sickened and died with two diseases that had never been observed in chimpanzees: Pneumocystis carinii pneumonia (later known as the "gay pneumonia" of AIDS) and leukemia, a cancer of the blood.

Because of the dangerous transfer of primate viruses into human cells, the VCP was a biological disaster waiting to happen. This possibility was recorded in the 1978 VCP report from the Office of Biohazard Safety stating: "The inadequate care and handling of animals during the past several years have created a potential for the occurrence of infection of humans with simian (primate) microorganisms and cross infection between species. Such interspecies disease transmission may seriously compromise the integrity of the experiment as well as the health of the experimenter. Due to the magnitude of biomedical research employing tissue cultures, frequent evaluation of tissue culture cross-contamination is very important."

A decade before Gallo discovered HIV, he reported a "new" and "human" and cancer-causing "HL-23 virus" that later turned out to be not one but three contaminating primate viruses (gibbon-ape virus, simian sarcoma virus, and baboon endogenous virus). How these three primate viruses contaminated Gallo's lab is unknown.

As late as 1986 Max Essex of Harvard "discovered" a new human
AIDS retrovirus found in the blood of healthy Africans. Eventually this virus
proved to be a monkey virus which traced back to a nearby primate colony in Massachusetts. In the first decade of AIDS Gallo and Essex were the leading proponents of the African green monkey theory of origin of AIDS.

In 1999 a team of researchers led by Beatrice Hahn (who worked in Gallo's lab when he proposed the green monkey theory) also claimed HIV traced back to chimpanzees in the African wild. This finding was quickly accepted as the true origin of HIV and AIDS; and the discovery was widely heralded in the media.

Did a KS virus originate from laboratory primate viruses?
A decade before AIDS, monkey cancer-causing viruses were adapted to human cells. In 1967 Herpesvirus saimiri, a harmless squirrel monkey virus closely related to the new KS herpes virus, was forced into different animals, such as the owl monkey, marmosets and rabbits, where it produced cancer in the form of malignant lymphoma. Lymphoma is a common cancer in AIDS patients; and there is also a close relationship between KS and lymphoma.

In 1971 Dharam V Ablashi of the NCI transferred H. saimiri into various cell lines of human origin. (1971;35). Attempts were made "to find a suitable method for the large-scale production of high-titer Herpesvirus saimiri" (1973;264). By 1976 it was also learned that H.saimiri was contagious and spread by "contact transmission" between squirrel and owl monkeys in the laboratory.

The Virus Cancer Program and secret human experimentation

A 1972 VCP Report (p. 262) emphatically states: "Since man will not be used as an experimental recipient, it is necessary to gain proof of oncogenicity by other means." How that "proof" would be obtained was never made clear.
With its close ties to military biowarfare research it is conceivable that the VCP undertook covert human testing of suspected cancer-causing viruses. The U.S. military has a long history of secret human experimentation on unsuspecting citizens. (Google: secret human experimentation + military). Were gay men used as guinea pigs to test the effects of these viruses?

In 1977 Merck and Co, Inc. made most of the experimental hepatitis B vaccine used in gays the following year. Merck's role in the VCP was "to conduct investigations designed to develop vaccines or other agents effective for the prophylaxis and therapy for human neoplasia (cancer) of suspected viral etiology" (1972 report; p 139).

Merck also wanted to develop an anti-herpes virus vaccine. Merck researchers stated: "Since live attenuated or killed virus vaccines for potentially oncogenic viruses would not be acceptable for human use due to the danger of transfer of functional genetic material, this project was initiated to determine whether vaccines to purified viral antigens acceptable for use in humans were of practical value." (1977;160) This proposed "purified" herpes vaccine was similar in type to the experimental "purified" hepatitis B vaccine injected into gays the following year in 1978.

"Gay cancer" and man-made laboratory "helper viruses"

The herpes KS virus is a "helper virus" which promotes cancer, particularly when combined with HIV. In the decade before AIDS it was discovered that some cancer-causing animal sarcoma viruses could not produce cancer unless a "helper virus" was present. For example, certain chicken, cat and mouse sarcoma viruses were "defective" in their ability to induce experimental cancer. But when a "helper" leukemia virus was added to the mix, the sarcoma virus was able to induce cancer.

By 1977, the year the experimental hepatitis B vaccine was being developed by Merck for use in gays , scientists in the VCP aimed "to determine the oncogenic [cancer-causing] potential of putative human viruses" and "to begin viral vaccine (conventional or other) testing and immunization programs" (1977 VCP Report; p32). The exact methods for accomplishing this were not stated. However, it is now obvious that the introduction of two new viruses into gay men conveniently accomplished this goal of VCP scientists: namely, to prove that immunosuppressive and cancer-causing retroviruses - with or without herpes KS-like "helper viruses" - could cause disease and cancer in humans.
The gay hepatitis B experiments (1978-1981) that preceded AIDS
HIV and the KS virus were introduced shortly after U.S. government scientists began recruiting large groups of gays from health clinics for the purpose of testing, treatment, and experimentation. It is my contention that this most hated minority in America afforded an opportunity to covertly test laboratory cancer viruses and "human candidate viruses" as specified in the VCR annual reports.

Were the primate "ancestors" of HIV and the KS herpes virus contained in some vials of the experimental hepatitis B vaccines? The extremely high incidence of both these "new" viruses in gays who volunteered for the vaccine experiments suggests this possibility.

The experimental vaccine was developed by Merck in chimpanzees and manufactured by purifying the pooled blood of 30 gay men who were hepatitis B virus carriers.[4] The volunteers in the experiment had to be free of the hepatitis B virus in order to test the efficacy of the vaccine.
During the first trial (November 1978-October 1979) at the New York Blood Center in Manhattan, there was great concern that the vaccine might be contaminated. According to June Goodfield's Quest for the Killers, p 86, "This was no theoretical fear, contamination having been suspected in one batch made by the National Institutes of Health, though never in Merck's." The 1,083 gay men were given three inoculations of the vaccine over a period of three months. The vaccine for each injection given to each man was contained within a one-dose individual vial.

The vaccine trial was a tremendous success with 96% of the men developing protective antibodies against the hepatitis B virus. [5,6] Some investigators condemning the man-made theory of AIDS have speculated that many of the men might have been already immunosuppressed by HIV before the experiment. However, in that case the 96% success rate could not have been achieved because immunosuppressed people frequently do not produce antibodies to the vaccine. Furthermore, there is no evidence that HIV existed in the U.S. blood supply before 1978, the year the gay experiments began.

Irrespective of how the two viruses were "introduced," it is a fact that government scientists quickly vilified gays and promoted AIDS as "gay-related immunodeficiency disease," and as "gay cancer" and "gay pneumonia." The disease was allowed to spread by the federal government which put budget ahead of the nation's welfare, and by disinterested health authorities who placed political expediency before the public health - and by scientists more concerned with international prestige than saving lives, as detailed by Randy Shilts in his classic book, And The Band Played On.

The end of the Virus Cancer Program and the birth of AIDS
The VCP ended in 1980 with the inability to prove that viruses were involved in human cancer. However, the VCP gave birth to genetic engineering, molecular biology, and the human genome project. The program built up the field of animal retrovirology, which led to a more complete understanding of how immunosuppressive and cancer-causing retroviruses caused disease. Naturally, this was helpful when the first cases of "gay cancer" erupted in 1979 in Manhattan and the epidemic was officially recognized in 1981.

As the VCP ended in 1980, more gay vaccine experiments began in other cities, such as San Francisco and Los Angeles. The vaccine trials ended in early 1981, just before the epidemic became official. These cities quickly became the primary epicenters of AIDS. Within a few years AIDS became the leading cause of death in young men in New York City; and that city would have the largest number of reported cases in the U.S. (7)

Being a participant in the government's hepatitis studies was clearly dangerous to a gay man's health. After HIV and the KS virus were introduced there was a definite increase in the cancer death rate in male homosexuals, not only from KS, but from non-Hodgkin's lymphoma, and other types of cancers as well. This was reported in Koblin's 1996 study of 15,565 gays in New York and San Francisco who participated in hepatitis B virus studies in the late 1970s.[8]
The introduction of HIV and the KS herpes virus into gay men miraculously revived the career of Robert Gallo and made him the most famous virologist in the world; and turned the failure of the VCP in 1980 into a triumph a few years later.

When Gallo's blood test for HIV became available in the mid-1980s, the New York Blood Center's stored gay blood specimens were reexamined for this virus. Most astonishing is the fact that 20% of the gay men in the Manhattan experiment were HIV-positive in 1980 (one year before the AIDS epidemic became "official"). These Manhattan gays in 1980 had the highest incidence of HIV anywhere in the world, including Africa, the supposed birthplace of HIV and AIDS. Forty percent of the men were HIV-positive in 1984. [9] And, as previously noted, one out of five gay men (20%) in an AIDS study group in New York City in 1982 tested positive for the new KS herpes-8 virus.[3]

It must be assumed that many of the men in the experiment eventually died of AIDS. The actual number of AIDS deaths has never been revealed. Attempts to secure this vital medical information have been rebuffed due to "confidentiality issues."

The origin and spread of the new Kaposi's Sarcoma virus

We are expected to believe that two primate viruses out of the African jungle "jumped species" -and ended up exclusively in the blood of white gay men in Manhattan in 1979. Such an unlikely biological scenario has the markings of a scientific fairy tale; and I remain stupefied that this theory has been so readily and universally accepted as "fact" by AIDS scientists.

In this regard, Patrick S Moore (a co-discoverer of the KS virus) claims the virus may have been introduced recently into the human population from a primate reservoir in Africa (''The emergence of Kaposi's sarcoma-associated herpesvirus,' New England Journal of Medicine [Editorial], November 9, 2000). Moore also alerts us to the danger of "xenotransplantation," whereby animal tissue and parts (along with animal viruses) are placed into human beings.

The distinct possibility that pre-AIDS primate experimentation was responsible for transferring HIV-like chimp and monkey viruses into humans is never mentioned by virologists. In addition, the AIDS establishment pooh-poohs any connection between the pre-AIDS gay experiments and the exclusive outbreak of HIV and the KS virus in homosexuals.

Also long forgotten are the millions of people (including half the U.S. population) injected with a cancer-causing monkey virus called simian (monkey) virus -40 which contaminated polio vaccines in the 1960s up to the late 1990s. For more details of this vaccine horror, see: and the recently published, The Virus and the Vaccine: The True Story of a Cancer-Causing Monkey Virus, Contaminated Polio Vaccine, and the Millions of Americans Exposed.

Once a rare virus, the KS virus is now widespread among "normal" blood donors. Donated blood is not routinely tested for the presence of the virus; and there is concern the KS virus could be further spread by blood transfusion. [10] In Texas 15% of blood donors now test positive for the KS virus. [11] A 2004 study indicates that up to 40% of men with prostate cancer (the most common form of cancer in men) have evidence of the KS virus in their blood. [12]

The man-made theory of AIDS and the Kaposi's sarcoma epidemic

In this current period of history when the origin of the Iraq war is shrouded in lies and deception at the highest levels of government, it is certainly conceivable that the origin of AIDS and two new viruses could also be shrouded in scientific secrecy, disinformation, misinformation, and government cover-up.

The evidence gathered here is merely a tiny fraction of the circumstantial evidence supporting the man-made origin of AIDS and the KS epidemics, both epidemics erupting immediately after a decade of dangerous animal cancer virus experimentation. The man-made theory has been fully explored in my two books, AIDS and the Doctors of Death and Queer Blood, as well as in Leonard G. Horowitz's Emerging Viruses, and in Robert E. Lee's AIDS: An Explosion of the Biological Time-Bomb. A Google search, using the key words "man-made origin of AIDS," reveals over 300 citations.

Although the scientific community and the media have totally ignored this subject for the past quarter-century, the man-made "conspiracy theory" of AIDS refuses to go away.

And finally, after all these years, it is time for medical science to admit that cancer can never be "gay" - or "straight."

[Dr. Alan Cantwell is a retired dermatologist; and the author of five books on the man-made origin of AIDS and the infectious origin of cancer, all published by Aries Rising Press, PO Box 29532, Los Angeles, CA 90029 ( Email: Abstracts of 30 published papers can be found at the PubMed website. Many of his personal writings can be found on by typing in key words "alan cantwell" + articles. His latest book is Four Women Against Cancer: Bacteria, Cancer and the Origin of Life. His books are available on and through Book Clearing House @ 1-800-431-1579]


1. KS enters Y2K still riddled with many questions.
J Natl Cancer Inst. 1999 Oct 6;91(19):1612-4.

2. Biggar RJ, Burnett W, Mikl J, Nasca P. Cancer among New York men at risk of acquired immunodeficiency syndrome. Int J Cancer. 1989 Jun 15;43(6):979-85.

3. O'Brien TR, Kedes D, Ganem D, Macrae DR, Rosenberg PS, Molden J, Goedert JJ. Evidence for concurrent epidemics of human herpesvirus 8 and human immunodeficiency virus type 1 in US homosexual men: rates, risk factors, and relationship to Kaposi's sarcoma. J Infect Dis. 1999 Oct;180(4):1010-7.

4. Szmuness W. Large-scale efficacy trials of hepatitis B vaccines in the USA: baseline data and protocols. J Med Virol. 1979;4(4):327-40.

5. Hoffman LJ, Bunker CH, Pellett PE, Trump DL, Patrick AL, Dollard SC, Keenan HA, Jenkins FJ. Elevated seroprevalence of human herpesvirus 8 among men with prostate cancer. J Infect Dis. 2004 Jan 1;189(1):15-20. Epub 2003 Dec 31.

6. Szmuness W, Stevens CE, Harley EJ, Zang EA, Oleszko WR, William DC, Sadovsky R, Morrison JM, Kellner. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med. 1980 Oct 9;303(15):833-41.

7. Koblin BA, Morrison JM, Taylor PE, Stoneburner RL, Stevens CE. Mortality trends in a cohort of homosexual men in New York City, 1978-1988. Am J Epidemiol. 1992 Sep 15;136(6):646-56.

8. Koblin BA, Hessol NA, Zauber AG, Taylor PE, Buchbinder SP, Katz MH, Stevens CE. Increased incidence of cancer among homosexual men, New York City and San Francisco, 1978-1990. Am J Epidemiol. 1996 Nov 15;144(10):916-23.

9. Stevens CE, Taylor PE, Zang EA, Morrison JM, Harley EJ, Rodriguez de Cordoba S, Bacino C, Ting RC, Bodner AJ, Sarngadharan MG, et al. Human T-cell lymphotropic virus type III infection in a cohort of homosexual men in New York City. JAMA. 1986 Apr 25;255(16):2167-72.

10. Dollard SC, Nelson KE, Ness PM, Stambolis V, Kuehnert MJ, Pellett PE, Cannon MJ. Possible transmission of human herpesvirus-8 by blood transfusion in a historical United States cohort. Transfusion. 2005 Apr;45(4):500-3.

11. Baillargeon J, Deng JH, Hettler E, Harrison C, Grady JJ, Korte LG, Alexander J, Montalvo E, Jenson HB, Gao SJ. Seroprevalence of Kaposi's sarcoma-associated herpesvirus infection among blood donors from Texas. Ann Epidemiol. 2001 Oct;11(7):512-8.

12. Hoffman LJ, Bunker CH, Pellett PE, Trump DL, Patrick AL, Dollard SC, Keenan HA, Jenkins FJ. Elevated seroprevalence of human herpesvirus 8 among men with prostate cancer. J Infect Dis. 2004 Jan 1;189(1):15-20.

Site Admin
Posts: 7781

Ex tells of HIV nightmare

Post#9 » Tue Jun 20, 2006 12:15 am

Sometimes, paybacks can be a bitch.
One should know whom one is screwwing around with, if you dont know, then get tested. Otherwise stfu. For some, they just cant keep their cock where it doesnt belong.

Ex tells of HIV nightmare,,2-2006280282,2.html

Aids avenger ... Sarah Jane Porter

Crime Editor

A BITTER blonde infected with the Aids virus went on a vengeful mission to spread the disease.

Sarah Jane Porter, 43, was made HIV positive by a black lover - and set out to pass it to other Afro-Caribbean men.

She is thought to have had unprotected sex with DOZENS.

The single mum, of Kennington, South London, was yesterday jailed for infecting one ex - and branded "pure evil".

A former lover of Porter told last night how she set out on a callous "payback mission".

The 37-year-old man - known as Mr B - called her "sick in the head".

And he told how she continued to sleep around even while awaiting trial for deliberately infecting another ex.

Mr B said: "She caught HIV off a black guy and now she's on a payback mission. All the guys she has slept with are black.

"Her thinking seems to be, 'Why should I be the only one to suffer? Why shouldn't they suffer as well?'.

"Sarah is very, very attractive - the sort of woman any guy would love to be with.

"But make no mistake, she is a very dangerous woman."

The lover she infected, known as Mr C, branded her "pure evil". Porter, a Vidal Sassoon salon receptionist, is thought to have had unprotected sex with DOZENS of young Afro-Caribbean men she met in nightclubs.

One is a well-known figure in the music world.

Yet she feigned shock and tears when Mr C discovered he was HIV positive - and let him believe HE had infected HER.

It was not until months later that the victim, an events manager, discovered through a mutual friend that Porter was carrying the deadly Aids virus BEFORE she met him.

She was jailed for 32 months at Inner London Crown Court yesterday for "recklessly" causing Mr C grievous bodily harm.

Wicked mum ... Porter with her son,
his identity disguised

Afterwards police appealed for any other men who may have slept with her to come forward for medical checks.

During a year-long investigation, cops contacted 2,000 people to ask them about her sexual history.

Porter, a regular London clubber who also travelled to dance events around the country, was diagnosed as an HIV carrier in 2000, soon after she gave birth to a son.

But it was not until May last year that police were tipped off about her vengeful pursuit by Mr B. He had been having regular unprotected sex with her until he was told about her condition at a barbecue.

She admitted she was HIV positive when he confronted her - and also confessed she had passed the virus to a former boyfriend. Mr B told how undaunted Porter still kept having sex with young black men while on bail.

He said: "A friend told me he slept with a good-looking blonde the night before. He said, 'Do you know a Sarah?' My jaw just dropped.

"At the same time Sarah was turning up at the police station telling them she was too ill to be interviewed.

"But my friends would see her dressed up, going out to clubs, dancing and flirting with other guys. She just wants others to suffer what she is going through."

Mr B had a HIV test, which was negative. But he contacted police, who then traced 24 men Porter is thought to have slept with.

Only three agreed to have checks, which all came back negative. Mr C had a two-year relationship with Porter, living part of the time at her flat in Kennington, South London. Prosecutor Tom Nicholson said: "It was, from his point of view, an exclusive relationship. And very early on he asked for the defendant to go with him to a clinic to be tested for sexual diseases.

"She said No and said she had already been cleared of any diseases when she had her son the previous year.

"Mr C believed what she said and went for a test himself, which was negative."

But he developed a sexual infection in May 2003 and had another check, which revealed he had the Aids virus.

Mr Nicholson said: "He immediately went back and told Ms Porter, and she broke down in tears." The boyfriend still faced a further test to confirm the diagnosis.
Mr Nicholson said: "She then said something to him that puzzled him, 'What if I've got it and you haven't'?"

Porter feigned tears again as she accompanied Mr C to the further check. And in July, to make her lies more convincing, she put herself up for a test - even though she had been diagnosed more than three years before.

Mr Nicholson said: "Of course it was confirmed she was HIV positive. Mr C was at the hospital and felt responsible for it.

"At no time during sexual intercourse, unprotected or otherwise, had she indicated she was HIV positive.

"He reports she was vague to the health adviser at the hospital. But he wasn't suspicious of her."

The prosecutor added: "A few months later he bumped into a friend who revealed that years previously the defendant told him she was HIV positive and wanted to make arrangements for her son. Mr C confronted her that night with the fact she had clearly been aware she was HIV positive. But Ms Porter denied it.

"She eventually admitted she had the virus, had known about it and must have infected him with it. His reaction was one of great upset."

Defence lawyer Wayne Cleaver said Porter had been "totally unable" to accept she was HIV positive. He claimed she could not admit it to herself - or to others.

But Judge Quentin Campbell told her she was "cruel and dishonest" and had devastated Mr C.

Porter sobbed as her wicked duplicity was outlined to the court.

But the cop in charge of the case, Detective Sergeant Brian McCluskey, revealed she had refused to help police trace her sexual partners.

He called Porter "callous and manipulative" and said she had set out to destroy lives.

He said: "I feel the men we have reached are the tip of the iceberg.

"Anyone who has slept with her needs to be warned for their own safety and for the sake of others.

"She went to a lot of dance nights in the West End and South London and in other parts of the country. This is a nationwide appeal."

The detective added: "She was once a victim herself. But all sympathy disappears when you consider how atrociously she has behaved. She has completely ruined the lives of the men involved."

Her parents Henry, 72, and Anita, 70, said they were devastated by the news. A tearful Mr Porter, of Cuffley, Herts, said: "We had no idea Sarah had Aids until I heard the news today. We're shocked.

"We haven't got on since she was 17 or 18 and left home."

Who is online

Users browsing this forum: No registered users and 1 guest